Select a Community
Are you sure you want to trigger topic in your Anconeus AI algorithm?
You are done for today with this topic.
Would you like to start learning session with this topic items scheduled for future?
Placental abruption
63%
149/236
Vasa previa
6%
13/236
Placenta accreta
8%
18/236
Preeclampsia
17%
39/236
Oligohydramnios
3%
6/236
Select Answer to see Preferred Response
The patient in this vignette will receive oxytocin to induce uterine contractions. Oxytocin is associated with an increased risk of placental abruption and uterine rupture. Oxytocin is a hormone that is produced in the hypothalamic paraventricular nucleus but stored and released by the posterior pituitary. The downstream effects of oxytocin include induction of uterine contractions and stimulation of milk letdown. It is commonly used to induce labor and control postpartum uterine bleeding. Incorrect Answers: Answer 2: Vasa previa is a pregnancy complication characterized by fetal blood vessels crossing or running adjacent to the uterine opening. It develops early in pregnancy and is not associated with oxytocin use. Answer 3: Placenta accreta is a pregnancy complication characterized by placental invasion into or past the myometrium. This can lead to heavy postpartum bleeding and an inability to deliver the placenta. It is not associated with oxytocin use. Answer 4: Preeclampsia is a disorder arising during pregnancy that is characterized by hypertension, proteinuria, and organ dysfunction. It is not associated with oxytocin use. Answer 5: Oligohydramnios is a pregnancy complication characterized by decreased amniotic fluid. It is not associated with oxytocin use. Bullet Summary: Oxytocin promotes uterine contractions in childbirth and is associated with an increased risk of placental abruption and uterine rupture.
3.7
(9)
Please Login to add comment